LR Health & Beauty announced its financial results for the fourth quarter 2025 and preliminary sales and earnings results for full year 2025. Revenue during the quarter was $80.3 million, a 10.9% decline that the company attributed to subdued consumer sentiment in Western European markets. The company said this impacted full-year 2025 results, which totaled $326.3 million in sales, a 4.6% year-over-year decrease.
Fourth quarter EBITDA was approximately $353,000. These results were particularly affected, the company said, by the lowers sales level and exceptional items as part of the realignment of the financing structure. Full-year 2025 EBITDA was $19.4 million, compared to $32.1 million in the previous year.
“In both financial and strategic terms, we are focusing consistently on creating the preconditions for sustainably positive business growth,” said Jörg Körfer, LR Health & Beauty SE CEO. “We have recently reached an important milestone with the agreement concerning a realignment of the financing structure. At the same time, it is important in 2026 to advance the LR Group’s business with suitable strategic initiatives. One focus in this context is the further development of our product portfolio. In the spring, we are planning the promising launch of a new generation of products that combines expertise from the health and beauty areas and will provide our distribution partners with fresh impetus for their business activities.”
The post LR Health & Beauty Reports Q4 2025 Financial Results first appeared on Direct Selling News.
